rs121909683
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_000821.7(GGCX):c.763G>A(p.Val255Met) variant causes a missense change. The variant allele was found at a frequency of 0.000131 in 1,613,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000821.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251332Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135838
GnomAD4 exome AF: 0.000139 AC: 203AN: 1461568Hom.: 0 Cov.: 31 AF XY: 0.000129 AC XY: 94AN XY: 727096
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74352
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Observed with an additional GGCX variant on the opposite allele (in trans) in siblings with features suggestive of pseudoxanthoma elasticum(PXE)-like disorder with multiple coagulation factor deficiency; other affected individuals in this family had the p.(V255M) variant as well as a pathogenic variant in the ABCC6 gene which is known to cause PXE, suggesting possible digenic inheritance (Li et al., 2009); Identified in patients with pulmonary arterial hypertension in published literature, but additional clinical information and familial segregation information were not provided (Zhu N et al., 2019); Published functional studies suggest this variant results in impairment of enzyme activity, however the exact mechanism of enzyme-substrate interaction is not well established (Li et al., 2009; Rishavy et al., 2012; Hao et al., 2021; Rishavy et al., 2022); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22516721, 35628569, 21453708, 33507293, 35767717, 28125048, 34816548, 18800149, 34906475, 33000479, 31727138) -
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 255 of the GGCX protein (p.Val255Met). This variant is present in population databases (rs121909683, gnomAD 0.009%). This missense change has been observed in individuals with GGCX-related conditions (PMID: 18800149, 28125048, 33000479, 34906475). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 16206). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on GGCX function (PMID: 18800149, 33507293, 34816548). For these reasons, this variant has been classified as Pathogenic. -
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency Pathogenic:1
- -
GGCX - Related Disorders Pathogenic:1
The c.763G>A (p.Val255Met) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. This variant has been previously reported as a heterozygous change in individuals with pulmonary arterial hypertension (PMID: 31727138) and as a compound heterozygous change in individuals with pseudoxanthoma elasticum-like disorder with or without combined deficiency of vitamin K-dependent clotting factors-1 (PMID: 34816548, 18800149, 33000479). Functional studies were conflicting, one study suggested that the c.763G>A (p.Val255Met) variant led to reduced carboxylation, while another study demonstrated higher levels of carboxylation (PMID: 33507293, 35767717, 34816548). The c.763G>A (p.Val255Met) variant is present in the heterozygous state in the gnomAD v4 population database at a frequency of 0.01% (212/1613752), and absent in the homozygous state, thus is presumed to be rare. Based on the available evidence, c.763G>A (p.Val255Met) is classified as Likely Pathogenic. -
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency;C1848534:Vitamin K-dependent clotting factors, combined deficiency of, type 1 Other:1
Variant interpreted as not provided and reported on 07-02-2014 by Lab or GTR ID 61756. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at